| __timestamp | Arrowhead Pharmaceuticals, Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 24419536 | 4042025 |
| Thursday, January 1, 2015 | 34718089 | 5279557 |
| Friday, January 1, 2016 | 40998209 | 8073913 |
| Sunday, January 1, 2017 | 32022880 | 44864073 |
| Monday, January 1, 2018 | 19110051 | 53488904 |
| Tuesday, January 1, 2019 | 26556257 | 65896361 |
| Wednesday, January 1, 2020 | 52275890 | 69968267 |
| Friday, January 1, 2021 | 80981000 | 92047281 |
| Saturday, January 1, 2022 | 124431000 | 131819000 |
| Sunday, January 1, 2023 | 90932000 | 87501000 |
| Monday, January 1, 2024 | 98761000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. From 2014 to 2023, Arrowhead Pharmaceuticals, Inc. and Pharming Group N.V. have shown distinct trends in their SG&A expenditures. Arrowhead Pharmaceuticals started with a modest 24% of its 2022 peak expenses in 2014, gradually increasing to a high in 2022. Meanwhile, Pharming Group N.V. exhibited a more volatile pattern, with a significant spike in 2017, reaching 34% of its 2022 peak. By 2023, both companies showed a reduction in SG&A costs, with Arrowhead Pharmaceuticals decreasing by 27% from its 2022 peak, while Pharming Group N.V. reduced by 34%. This data highlights the dynamic strategies employed by these companies in managing operational costs, reflecting their adaptability in a rapidly evolving industry.
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Pharming Group N.V.
Biogen Inc. or Pharming Group N.V.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: BeiGene, Ltd. vs Arrowhead Pharmaceuticals, Inc.
Genmab A/S and Pharming Group N.V.: SG&A Spending Patterns Compared
Viatris Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Exelixis, Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Breaking Down SG&A Expenses: Pharming Group N.V. vs Apellis Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Pharming Group N.V. and Amneal Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Grifols, S.A. and Arrowhead Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Corcept Therapeutics Incorporated vs Arrowhead Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of HUTCHMED (China) Limited and Arrowhead Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Arrowhead Pharmaceuticals, Inc. and MannKind Corporation